Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Treating prolactinoma doesn't significantly affect hirsutism or cause high androgen levels.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Oral contraceptives with cyproterone acetate improved quality of life for women with PCOS more than those with levonorgestrel.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

The combined therapy improved symptoms in PCOS patients.

Nonactivated low leukocyte PRP injections can significantly increase hair and follicle density in women with alopecia.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

A woman's temporary hair loss was caused by high prolactin levels from her medication.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Neuropsychiatric lupus is a severe form of lupus that needs strong treatment to improve life quality.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

Endocrine therapy helps with reproductive and metabolic issues in women with PCOS.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.